Literature DB >> 3370183

Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease.

A Bush1, C M Busst, S G Haworth, A A Hislop, W B Knight, B Corrin, E A Shinebourne.   

Abstract

Pulmonary vascular resistance was measured in air, oxygen, and after administration of vasodilators in 14 children with pulmonary hypertension and congenital heart disease. Lung morphology was examined by light microscopy and assessed quantitatively. In this selected group of patients (a) medial muscle thickness of greater than 20% in the intra-acinar arteries and Heath-Edwards changes of I or II were significantly associated with perioperative death from pulmonary complications after cardiac surgery; (b) children with lower percentage medial muscle thickness had a higher baseline resistance (r = -0.84) associated with Heath-Edwards grade III or higher changes (most of these patients were not offered corrective surgery); (c) when the lowest pulmonary vascular resistance was less than 3 units, Heath-Edwards grading was I or II (n = 4). When the pulmonary vascular resistance was greater than 6 units, however, there was no direct correlation with Heath-Edwards grading (n = 9). Four patients with a resistance of greater than 6 units had only grade I or II changes. Three had a medial muscle thickness above 20%, and were among those who died at or soon after operation. It is concluded that (a) patients with a lowest pulmonary vascular resistance of greater than 6 units have a bad prognosis whatever their lung morphology; and (b) some patients with Heath-Edwards grade I or II will have a high resistance (this group has a high medial muscle mass and a poor prognosis and would not be detected by Heath-Edwards grading alone).

Entities:  

Mesh:

Year:  1988        PMID: 3370183      PMCID: PMC1216495          DOI: 10.1136/hrt.59.4.480

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  17 in total

1.  The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects.

Authors:  D HEATH; J E EDWARDS
Journal:  Circulation       Date:  1958-10       Impact factor: 29.690

2.  Effect of environmental temperatures on oxygen consumption in infants with congenital disease of the heart.

Authors:  C T Kappagoda; F J Macartney
Journal:  Br Heart J       Date:  1976-01

3.  The measurement of metabolic gas exchange and minute volume by mass spectrometry alone.

Authors:  N J Davies; D M Denison
Journal:  Respir Physiol       Date:  1979-02

4.  Effects of surgical closure of ventricular septal defects upon pulmonary vascular disease.

Authors:  K A Hallidie-Smith; A Hollman; W P Cleland; H H Bentall; J F Goodwin
Journal:  Br Heart J       Date:  1969-03

5.  Early and late results of surgical repair of truncus arteriosus.

Authors:  C Marcelletti; D C McGoon; G K Danielson; R B Wallace; D D Mair
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

6.  Pulmonary vascular development: normal values of peripheral vascular structure.

Authors:  S G Haworth; A A Hislop
Journal:  Am J Cardiol       Date:  1983-09-01       Impact factor: 2.778

7.  Pulmonary vascular resistance in children with congenital heart disease.

Authors:  N J Davies; E A Shinebourne; M J Scallan; T A Sopwith; D M Denison
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

8.  Magnification pulmonary wedge angiography in the evaluation of children with congenital heart disease and pulmonary hypertension.

Authors:  M R Nihill; D G McNamara
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

9.  Pulmonary vascular disease in children with truncus arteriosus.

Authors:  E Juaneda; S G Haworth
Journal:  Am J Cardiol       Date:  1984-12-01       Impact factor: 2.778

10.  Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease.

Authors:  M Rabinovitch; S G Haworth; A R Castaneda; A S Nadas; L M Reid
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

View more
  7 in total

1.  Closure of a large patent ductus arteriosus in adults: first do no harm.

Authors:  Michael L Rigby
Journal:  Heart       Date:  2007-04       Impact factor: 5.994

2.  The short- and medium-term results of transcatheter closure of atrial septal defect with severe pulmonary arterial hypertension.

Authors:  Zhi-wei Huang; Zhi-xin Fan; Jian-tao Sun; Wei-min Li; Yan-qing Gao; Yi-hua Quan; Ya-ming Geng; Yan-yan Niu; Bing-xiang Wu
Journal:  Heart Vessels       Date:  2011-09-17       Impact factor: 2.037

3.  Successful repair of an atrial septal defect associated with right to left shunting.

Authors:  K F Hossack; J C Tewksbury; L M Reid
Journal:  Br Heart J       Date:  1989-07

4.  Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry.

Authors:  Kevin D Hill; D Scott Lim; Allen D Everett; D Dunbar Ivy; J Donald Moore
Journal:  Catheter Cardiovasc Interv       Date:  2010-11-15       Impact factor: 2.692

Review 5.  Nitric oxide for the evaluation and treatment of pulmonary hypertension in congenital heart disease.

Authors:  J P Kovalchin; A R Mott; K L Rosen; T F Feltes
Journal:  Tex Heart Inst J       Date:  1997

6.  Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces.

Authors:  Maria Jesus Del Cerro; Shahin Moledina; Sheila G Haworth; Dunbar Ivy; Maha Al Dabbagh; Hanaa Banjar; Gabriel Diaz; Alexandria Heath-Freudenthal; Ahmed Nasser Galal; Tilman Humpl; Snehal Kulkarni; Antonio Lopes; Ana Olga Mocumbi; G D Puri; Beyra Rossouw; S Harikrishnan; Anita Saxena; Patience Udo; Lina Caicedo; Omar Tamimi; Ian Adatia
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

7.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease.

Authors:  Antonio Lopes; Khalid Alnajashi
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.